Gensol’s Rs 395.49 crore warrant balance remains unverified
Key highlights
- Crisil could not verify Rs 395.49 crore linked to Gensol warrant conversions for the quarter ended September 30, 2026.
- Gensol’s revised preferential-issue size was Rs 538.60 crore, compared with an original Rs 900.10 crore.
- Gensol received Rs 134.65 crore as initial warrant subscription money in the quarter ended June 30, 2024.
- Historically reported utilisation was Rs 142.93 crore, but Crisil could not confirm the September 2026 position.
powered by IRIS

Gensol Engineering Limited’s Rs 395.49 crore balance linked to warrant conversions remained unverified for the quarter ended September 30, 2026, because Crisil Ratings Limited did not receive required records. Crisil also said Gensol’s share price had fallen significantly below the preferential-issue warrant price, which may deter payment of the remaining amount.
Know Gensol Engineering inside out
Results, valuation, peers and who's buying, in one view.
Why could Crisil not verify Gensol’s warrant-conversion balance?
Crisil could not comment on the Rs 395.49 crore balance towards warrant conversion because Gensol did not provide documents and information for the quarter ended September 30, 2026. The monitoring agency issued a qualified report with the status “issuer not cooperating” under its February 5, 2024 monitoring agreement for the preferential issue.
The information gap covered the quarters ended March 31, June 30, September 30 and December 31, 2025, as well as March 31, June 30 and September 30, 2026. Crisil said it requested records through emails dated September 11, October 8 and October 16, 2026, a letter dated October 30, and another email dated November 5, but the issuer remained non-cooperative.
This was a continuation of qualified monitoring reports dated May 15, August 14 and November 13, 2025, and February 13, May 15 and August 14, 2026. Crisil said the absence of records prevented it from monitoring use of issue proceeds, testing whether spending matched the stated objects, assessing implementation delays, or determining deployment of unutilised funds.
Gensol is undergoing the Corporate Insolvency Resolution Process, or CIRP, and the board’s powers are suspended and exercised by Resolution Professional Keshav Khaneja. The Resolution Professional told Crisil that the CIRP had left it without complete historical books, records and supporting documents to independently verify the preferential-issue proceeds.
How large was Gensol’s warrant issue and reported funding?
Gensol’s revised preferential-issue size was Rs 538.60 crore, lower than the original Rs 900.10 crore, after undersubscription of the June 18, 2024 warrant issue. The revised amount assumed conversion of all allotted warrants into equity shares and receipt of the related conversion money.
The issuer received Rs 134.65 crore, or 25% of the revised issue size, as subscription money during the quarter ended June 30, 2024. It also reported receiving Rs 8.46 crore from warrant conversions during the quarter ended September 30, 2024, according to earlier monitoring disclosures cited by Crisil.
Gensol informed stock exchanges on March 10, 2025 that it had allotted 443,934 equity shares after conversion of 443,934 warrants in the promoter category, following reported receipt of Rs 29.00 crore. Crisil said no bank statements or comparable evidence were submitted to allow verification of that reported payment.
The Rs 395.49 crore figure is therefore not described by Crisil as confirmed cash, a verified receivable, or an audited outstanding amount. It is the balance associated with warrant conversion on which Crisil could not comment because information was unavailable for the reporting periods from March 31, 2025 through September 30, 2026.
Got a follow-up? Ask IRIS
What were Gensol’s planned uses for the revised proceeds?
Gensol’s largest revised allocation was Rs 194.47 crore for working-capital requirements, followed by Rs 119.68 crore for investment in a leasing subsidiary. The issue objects were reduced proportionately after the June 2024 undersubscription, an approach supported by a legal opinion dated August 5, 2024 from Wadia Ghandy & Co.
The remaining revised allocations were Rs 68.81 crore for investment in a manufacturing subsidiary, Rs 50.86 crore for inorganic growth opportunities and Rs 104.77 crore for general corporate purposes. Together, the five objects totalled Rs 538.60 crore, down by Rs 361.50 crore from the original aggregate plan of Rs 900.10 crore.
Working capital accounted for Rs 115.40 crore of the Rs 142.93 crore total historically reported utilisation, while no utilisation was reported for inorganic growth opportunities. Crisil stressed that it could not confirm utilisation during the September 2026 quarter or the status of any object because Gensol did not provide supporting documentation.
Crisil also could not establish whether the revised object costs changed after December 31, 2024. This limitation applies to all seven quarters from March 31, 2025 to September 30, 2026 and includes the Rs 104.77 crore designated for general corporate purposes.
What could affect Gensol’s remaining warrant conversions?
Crisil said Gensol’s current share price had dropped significantly below the warrant price offered in the preferential issue. The agency said this may deter investors from paying the remaining amount and may severely affect Gensol’s ability to achieve the objects attached to the Rs 538.60 crore issue.
The report does not disclose the warrant exercise price, the current market price, or an estimate of how many warrants may eventually convert. Crisil’s observation is a stated risk to further collections rather than a confirmed forecast of the outcome for the Rs 395.49 crore balance.
The monitoring report also recorded that credit-rating agencies revised Gensol’s ratings to default in March 2025 due to delays in servicing debt obligations. It cited the company’s April 24, 2025 disclosure of the Securities and Exchange Board of India’s April 15, 2025 interim order, which barred Gensol and its two named promoters from the securities market and from director or key managerial positions, and ordered a forensic audit.
Crisil further cited Gensol’s April 28, 2025 disclosure that the Directorate of Enforcement had conducted search and seizure action under the Foreign Exchange Management Act, 1999. Separately, according to Gensol’s July 14, 2026 announcement, Indian Renewable Energy Development Agency classified the loan accounts of Gensol and Gensol EV Lease Limited as “Fraud” under the Reserve Bank of India’s 2024 Fraud Risk Management Directions.
Conclusion
Crisil’s September 2026 report leaves the Rs 395.49 crore warrant-conversion balance and the use of preferential-issue proceeds unverified because Gensol did not provide required records. The issue’s revised planned size was Rs 538.60 crore, while Rs 142.93 crore was historically reported as utilised at the beginning of the quarter, without confirmation of the September-quarter position.
The next disclosed process to watch is the CIRP resolution exercise and whether records become available to the Resolution Professional or Crisil. The Resolution Professional published Form G seeking expressions of interest on September 30, 2025, and the report states that the deadline for submitting resolution plans was December 14, 2025.


